Circumventing Doxorubicin Resistance Using Elastin-like Polypeptide Biopolymer-Mediated Drug Delivery

Although doxorubicin (dox), an anthracycline antibiotic, is widely used and effective in treating cancer, its treatment efficiency is limited by low blood plasma solubility, poor pharmacokinetics, and adverse side effects, including irreversible cardiotoxicity. Moreover, cancer cells often develop d...

Descripción completa

Detalles Bibliográficos
Autores principales: Dragojevic, Sonja, Turner, Lindsay, Raucher, Drazen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878013/
https://www.ncbi.nlm.nih.gov/pubmed/35216417
http://dx.doi.org/10.3390/ijms23042301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878013/
https://www.ncbi.nlm.nih.gov/pubmed/35216417
http://dx.doi.org/10.3390/ijms23042301

Ejemplares similares